Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum thyroglobulin and recurrent thyroid cancer.

P L Gerfo, T Stillman, D Colacchio

    Lancet (London, England)
    |April 23, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sequential occurrence of toxic nodular goiter followed by Graves' disease.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2004
    Same author

    Detection of circulating thyroid cells in peripheral blood.

    Surgery·1996
    Same author

    Parathyroid surgery using monitored anesthesia care as an alternative to general anesthesia.

    American journal of surgery·1996
    Same author

    A novel tumor-derived mediator that sensitizes cytokine-resistant tumors to tumor necrosis factor.

    The Journal of surgical research·1996
    Same author

    Thyroid surgery using monitored anesthesia care: an alternative to general anesthesia.

    Thyroid : official journal of the American Thyroid Association·1994
    Same author

    The intraoperative incidence of detectable bilateral and multicentric disease in papillary cancer of the thyroid.

    Surgery·1990

    Serum thyroglobulin is a valuable tumor marker for detecting recurrent thyroid cancer after total thyroidectomy. Elevated levels indicate disease recurrence, while minimal levels suggest a disease-free state in athyroid patients.

    Area of Science:

    • Endocrinology
    • Oncology
    • Biomarker Discovery

    Background:

    • Thyroid malignancies often produce thyroglobulin.
    • Post-thyroidectomy, thyroglobulin levels should be minimal.
    • Serum thyroglobulin can serve as a tumor marker for recurrent disease.

    Purpose of the Study:

    • To evaluate serum thyroglobulin as a tumor marker for recurrent thyroid malignancy.
    • To assess the utility of thyroglobulin levels in athyroid patients post-thyroidectomy.

    Main Methods:

    • Studied 30 athyroid patients who underwent total thyroidectomy for malignancy.
    • Measured serum thyroglobulin levels in disease-free patients and those with recurrences.
    • Compared patient levels to control ranges (0-60 ng/ml).

    Related Experiment Videos

    Main Results:

    • 20 disease-free patients had minimal thyroglobulin (<15 ng/ml).
    • 10 patients with recurrence had elevated thyroglobulin (>90 ng/ml).
    • Serum thyroglobulin levels effectively differentiated between disease-free and recurrent states.

    Conclusions:

    • Serum thyroglobulin is a simple and specific marker for recurrent thyroid cancer.
    • This assay is valuable for monitoring patients after total thyroidectomy for malignancy.